76 related articles for article (PubMed ID: 12579770)
1. [Tyrosine kinase receptor-mediated signal transduction and cancer treatment].
Zhu XF; Liu ZC; Zeng YX
Yao Xue Xue Bao; 2002 Mar; 37(3):229-34. PubMed ID: 12579770
[No Abstract] [Full Text] [Related]
2. [Future perspectives. From basic research to the development of new therapies aimed at the inhibition of the different stages of signal transduction: applications in breast cancer].
Campone M; Kerbrat P; Roché H; Bennouna J; Cuillière JC; Le Mevel B; Fumoleau P
Bull Cancer; 2003 Oct; 90(10):851-64. PubMed ID: 14706914
[TBL] [Abstract][Full Text] [Related]
3. [Lung cancer: molecular targeting therapy].
Kobayashi K
Nihon Kokyuki Gakkai Zasshi; 2004 May; 42(5):371-7. PubMed ID: 15168452
[No Abstract] [Full Text] [Related]
4. Lapatinib: new directions in HER2 directed therapy for early stage breast cancer.
Jo Chien A; Rugo HS
Cancer Treat Res; 2009; 151():197-215. PubMed ID: 19593514
[No Abstract] [Full Text] [Related]
5. [Trastuzumab. Monoclonal antibody for the treatment of breast cancer].
Heinzl S
Med Monatsschr Pharm; 2000 Nov; 23(11):350-2. PubMed ID: 11103587
[No Abstract] [Full Text] [Related]
6. [Tyrosine kinase inhibitors in tumor therapy--part 1. Molecular and genetic fundamentals].
Grimm CF; Blum HE; Geissler M
Dtsch Med Wochenschr; 2005 May; 130(21):1318-22. PubMed ID: 15902620
[No Abstract] [Full Text] [Related]
7. The insulin-like growth factor signaling pathway as a target for treatment of colorectal carcinoma.
Ewing GP; Goff LW
Clin Colorectal Cancer; 2010 Oct; 9(4):219-23. PubMed ID: 20920993
[TBL] [Abstract][Full Text] [Related]
8. Managing trastuzumab-resistant breast cancer.
Krop I
Clin Adv Hematol Oncol; 2009 Feb; 7(2):108-10. PubMed ID: 19367251
[No Abstract] [Full Text] [Related]
9. A brake becomes an accelerator: PTP1B--a new therapeutic target for breast cancer.
Tonks NK; Muthuswamy SK
Cancer Cell; 2007 Mar; 11(3):214-6. PubMed ID: 17349579
[TBL] [Abstract][Full Text] [Related]
10. ERBB2 phosphorylation and trastuzumab sensitivity of breast cancer cell lines.
Ginestier C; Adélaïde J; Gonçalvès A; Repellini L; Sircoulomb F; Letessier A; Finetti P; Geneix J; Charafe-Jauffret E; Bertucci F; Jacquemier J; Viens P; Birnbaum D
Oncogene; 2007 Nov; 26(50):7163-9. PubMed ID: 17525746
[TBL] [Abstract][Full Text] [Related]
11. First MAb approved for treatment of metastatic breast cancer.
Brenner TL; Adams VR
J Am Pharm Assoc (Wash); 1999; 39(2):236-8. PubMed ID: 10079656
[No Abstract] [Full Text] [Related]
12. Trastuzumab in the treatment of breast cancer.
Hortobagyi GN
N Engl J Med; 2005 Oct; 353(16):1734-6. PubMed ID: 16236745
[No Abstract] [Full Text] [Related]
13. Trastuzumab in breast cancer.
Banna GL; Santoro A
N Engl J Med; 2006 Feb; 354(6):640-4; author reply 640-4. PubMed ID: 16470951
[No Abstract] [Full Text] [Related]
14. Trastuzumab in breast cancer.
Gounaris IG
N Engl J Med; 2006 Feb; 354(6):640-4; author reply 640-4. PubMed ID: 16470950
[No Abstract] [Full Text] [Related]
15. Herceptin.
Shepard HM; Jin P; Slamon DJ; Pirot Z; Maneval DC
Handb Exp Pharmacol; 2008; (181):183-219. PubMed ID: 18071947
[TBL] [Abstract][Full Text] [Related]
16. Trastuzumab in breast cancer.
Gilbert SG
N Engl J Med; 2006 Feb; 354(6):640-4; author reply 640-4. PubMed ID: 16467555
[No Abstract] [Full Text] [Related]
17. Advances in targeting human epidermal growth factor receptor-2 signaling for cancer therapy.
Meric-Bernstam F; Hung MC
Clin Cancer Res; 2006 Nov; 12(21):6326-30. PubMed ID: 17085641
[TBL] [Abstract][Full Text] [Related]
18. [New development in the treatment of breast cancer. II. Future anti-HER2 therapy].
Yamashita T; Iwata K
Gan To Kagaku Ryoho; 2009 Dec; 36(13):2551-4. PubMed ID: 20104676
[No Abstract] [Full Text] [Related]
19. [Predictive value of Her2/neu expression/amplification for the targeted treatment of breast cancer].
Lehr HA; Schaefer SC; Delaloye JF
Rev Med Suisse; 2009 Jul; 5(211):1525-9. PubMed ID: 19694364
[TBL] [Abstract][Full Text] [Related]
20. [Tyrosine kinases. New target of anticancer therapy].
Majsterek I; Pytel D; Błasiak J
Postepy Biochem; 2005; 51(3):251-60. PubMed ID: 16381169
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
